Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
about
Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trialRole of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysisGabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years.Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients.Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.Pancreatitis after endoscopic retrograde cholangio-pancreatography.Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitisSystematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis.Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.Antioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: What does evidence suggest?Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitisIndomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?Reducing the incidence and severity of post ERCP pancreatitis.Aggressive hydration with Lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial.Post-ERCP pancreatitis and its prevention.Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial.Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography.Pharmacological approach to acute pancreatitis.Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitisPost-endoscopic retrograde cholangiopancreatography pancreatitis: Risk factors and predictors of severity.Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?Complications of ERCP.Clinical practice guideline for post-ERCP pancreatitis.Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate.Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.Double balloon enteroscopy and acute pancreatitis.Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.Trypsin secretion and turnover in patients with acute pancreatitis.Brushing the distal biliary stricture in the surrounding of the papilla increased the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: A retrospective study using propensity score analysis.A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.Risk factors for post-ERCP pancreatitis: a prospective multicenter study.Different pattern of risk factors for post-ERCP pancreatitis in patients with biliary stricture.Wire-guided cannulation for endoscopic retrograde cholangiopancreatography: now is the time to teach trainees a standardized technique.Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities?Prevention of Post-ERCP Pancreatitis
P2860
Q24658599-38DD9090-CA4D-4998-BECB-D4D100137FFEQ28077968-FDA0CF24-684E-48ED-B05E-94AD7CFFD404Q33273455-6AF63EF8-429C-4107-A63E-A2FFDE84DAACQ33673959-D83058E3-069E-411E-9C50-726D3AEE0BCFQ33837450-BEDA1DB5-53B6-4FF5-B2D4-594C8C7FC882Q34098709-75D52675-204E-4BCA-AA06-AA980BDD6122Q34100027-CE76A528-024B-4FEA-844D-35B9DBF62EF5Q34307844-4895D0A2-6B9C-450D-BD8B-6F038BAED882Q34390035-6C4BAFA0-CA30-4814-85AC-A6F9872EAA82Q34647451-AB2E01D7-5581-4C07-A63E-D6BDF209EA36Q35020441-9929810F-AA76-4FEC-B0F8-C3EF0BB3E48EQ35137859-E147FBE8-1261-4B30-8C3D-685137F7A5A0Q35692361-D4A4A5AA-EE2C-4B3A-9738-48B6A0585CA6Q35865775-CE806B5B-716D-4A62-B13D-9CDCCC104CEBQ35931242-4F33E847-3107-4009-85E5-3DEA70647107Q36175025-0D468671-BE56-4745-B20D-523E2E4ECC7CQ36235411-E66C332D-0D2E-48FC-A745-E2B29677A141Q36417258-86D83BFE-7055-447B-8D40-AB6305A38C93Q36666312-27944787-5235-4577-9066-664D14A09E9AQ37122261-5C9AD1BD-0226-41CC-9A7B-B9A8B5629FC5Q37160556-A22EA269-3FBD-4A1A-A0CE-88C2E36FC58DQ37169329-43049B1A-DA78-47DE-A55F-32EBBF76C258Q37318552-9B9858AC-E0F0-4D02-BD71-1B65B9D7E543Q37421464-2BEC1C69-3BCA-4416-AA8F-1485EE8CB223Q38092636-B12CF64C-CE2C-4C79-AFCB-50CDF04B1342Q38138483-691A5993-4CA2-4339-9D7C-358A37AFF169Q38707817-8661B2D8-7A35-4F94-9F31-F45B33F80538Q39977899-1B80B20B-F7AE-4EF6-A266-1244E3E170EFQ41248351-A74CD8CE-5F46-4F76-9822-6D4F9768030FQ42774354-037FD314-B9E0-49EB-967A-6674BC6FA7AFQ44840107-29827CFC-01A1-4C49-80B3-D58567AB7FA9Q45261157-E985DEF9-5F2B-4BB4-99A8-DC54641CFCC3Q46031267-E1D0B3D6-8BEA-496F-82CF-FA0E380B77E2Q46816235-86D91C55-FA95-49EF-9799-987ABBDFF36DQ46888787-B8BBE58C-3272-43BB-99CD-51ECA20D9866Q47585906-E7CF2DB1-D914-4DE9-A04B-20A214029930Q53404711-AF57688E-6142-4DFE-A60F-BAB89AB1A993Q58559833-A01B316D-447D-4682-82FC-08223D02D4EDQ58701407-DE6C6BCD-06BD-4724-92C6-3B818A6F8EDC
P2860
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@en
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@nl
type
label
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@en
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@nl
prefLabel
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@en
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@nl
P2093
P1476
Gabexate or somatostatin admin ...... ed, randomized clinical trial.
@en
P2093
Angelo Andriulli
Angelo Sigillito
Francesco Perri
Giovanni De Maio
Luigi Solmi
Pietro Leo
Renzo Suriani
Rocco Clemente
Vittorio Terruzzi
P304
P356
10.1016/S0016-5107(02)70431-8
P407
P577
2002-10-01T00:00:00Z